Cyfkod T 250mg/31.25mg Injection
Marketer
Kosmed Formulations
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cyfkod T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be strictly under a physician's guidance; adhere to all scheduled doses. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Nausea, vomiting, diarrhea, and dyspepsia are possible side effects; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, a balanced diet, and ample hydration promote faster recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Cyfkod T 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cyfkod T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cyfkod T 250mg/31.25mg Injection:
Administering this medication will be performed by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cyfkod T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cyfkod T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
How Cyfkod T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Cyfkod T 250mg/31.25mg) unites a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. The addition of Tazobactum counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cyfkod T 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Cyfkod T 250mg/31.25mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cyfkod T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Cyfkod T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cyfkod T 250mg/31.25mg Injection to individuals with impaired renal function. Seek medical advice.
LiverCAUTION
Exercise caution when administering Cyfkod T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the dose of Cyfkod T 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cyfkod T 250mg/31.25mg Injection :
Omit a dose of Cyfkod T 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Cyfkod T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently